Cell line · CVCL_8794
MM1.R
Cancer cell line, Homo sapiens. Plasma cell myeloma. 18 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. MM1.R. Cell lines, record CVCL_8794. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_8794
On this page
Cell line
As Cellosaurus gives it.
- Name
- MM1.R
- Accession
- CVCL_8794
- RRID
- RRID:CVCL_8794
- Synonyms
- MM1.r, MM.1R, MM1-R, MM-1R, MM1R, MM1.R(L), MM1.RL
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 45Y
- Category
- Cancer cell line
- Diseases
- Plasma cell myeloma (NCIt C3242); Multiple myeloma (ORDO Orphanet_29073)
- Derived from
- Peripheral blood (in situ)
- Cell type
- Plasma cell
- Parent
- MM.1 (CVCL_5801)
- Entry created
- 2012-06-06
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers18
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib. | Br J Haematol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma. | Adv Healthc Mater | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma. | Cancer Cell Int | 2024 | Its Methods give the RRID and name the line | PubMed | |
| CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy. | EBioMedicine | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 18
See all 18 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | MM.1 | CVCL_5801 |
Source Cell lines
Cell banks3
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8032 | ABM | |
| ATCC | CRL-2975 | ATCC | |
| IZSLER | BS TCL 235 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_8794
GET https://conductscience.org/api/cell-lines/v1/CVCL_8794/problems